Search PubMed⌕ Search

PubMed · 11688345

[Viral hepatitis E. Current knowledge and future problems].

Abstract

Hepatitis E is the principal enterically-transmitted non-A, non-B, non-C hepatitis, responsible for large epidemics of acute hepatitis associated with fecal contamination of drinking water in under-developed and developing countries. In contrast, in the industrialized world, the infection occurs rarely and sporadically, usually in individuals who originated from or traveled to regions of known endemism. However, serological and virological studies have provided evidence that hepatitis E virus may be circulating in geographical areas not previously considered to be endemic. Hepatitis E is a self-limiting, acute disease with an overall mortality rate of 0.4-4%, although a more severe course has been observed in pregnant women, in whom mortality can rise to 20%. Enzyme immunoassays and polymerase chain reaction are available for definitive diagnosis. The immune serum globulins have not evidenced certain beneficial effects during hepatitis E epidemics, and candidate vaccines have not yet reached the clinical trial stage.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L Calza, E Briganti, G Verucchi, F Chiodo. [Viral hepatitis E. Current knowledge and future problems].. https://pubmed.ncbi.nlm.nih.gov/11688345/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Use of the most likely failure point method for risk estimation and risk uncertainty analysis.

The most likely failure point (MLFP) method, developed within the field of structural reliability analysis (where it is known as the FORM/SORM method) is a technique for estimating the risk (probability) that a calculated quantity Q exceeds a set limit Q(lim) when some or all of the inputs to the calculation are uncertain. It can be used as an efficient stand-alone method for this type of risk calculation. However, for application within the field of toxic hazards, it is proposed as a means for performing sensitivity analyses, possibly in parallel with a risk calculation carried out by conventional methods. The basis of the method is outlined and its use is demonstrated by means of an example calculation of the risk arising from an installation containing chlorine. The calculation uses, as a consequence model, commercial software for the prediction of dense gas transport. The risk estimate is shown to be acceptably close to that obtained by the Monte Carlo method. The use of a proposed screening procedure utilising the sensitivity formulas that the method provides, in order to identify the most significant uncertainties, is demonstrated. The identification of a single set of input values containing sufficient information to summarise (at least approximately) the entire risk analysis is considered to be an important feature of the method and is proposed as the basis of a means for assessing the validity of the consequence model.

Forecasting↗

Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences.

Superinfection with multiple strains or subtypes of the human and simian immunodeficiency viruses has been documented. Recent increases in the prevalences of both unprotected anal intercourse and sexually transmitted diseases among men who have sex with men indicate that these men continue to practice unsafe sex and, therefore, are at risk for superinfection with the human immunodeficiency virus (HIV). Recurrent exposure to HIV among seropositive individuals who engage in high-risk behaviors can have serious consequences, because superinfection is a necessary first step for viral recombination to occur. Recombination may produce more virulent viruses, drug-resistant viruses, or viruses with altered cell tropism. Additionally, recombinant viruses and superinfection can accelerate disease progression and increase the likelihood of sexual transmission by increasing virus load in the blood and genital tract. The extent of superinfection and recombination in persons living with HIV is unknown. The implications of HIV superinfection and the generation of recombinant viruses are discussed.

Forecasting↗